BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fung J. Management of chronic hepatitis B before and after liver transplantation. World J Hepatol 2015; 7(10): 1421-1426 [PMID: 26052387 DOI: 10.4254/wjh.v7.i10.1421]
URL: https://www.wjgnet.com/1948-5182/full/v7/i10/1421.htm
Number Citing Articles
1
A.J. Demetris, C.O.C. Bellamy, C.R. Gandhi, S. Prost, Y. Nakanuma, D.B. Stolz. Functional Immune Anatomy of the Liver—As an AllograftAmerican Journal of Transplantation 2016; 16(6): 1653 doi: 10.1111/ajt.13749
2
Vahid Babaei, Masoud Ghorbani, Nastaran Mohseni, Hojjat Afraid, Yassaman Saghaei, Shahram Teimourian. Clinical correlations between chronic hepatitis C infection and decreasing bone mass density after treatment with interferon-alphaAsian Pacific Journal of Tropical Biomedicine 2017; 7(2): 161 doi: 10.1016/j.apjtb.2016.11.027
3
Ka Wing Ma, Kenneth Siu Ho Chok, James Yan Yue Fung, Chung Mau Lo. Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong KongJournal of Clinical and Translational Hepatology 2018; (x): 1 doi: 10.14218/JCTH.2017.00058
4
James Fung, Tiffany Wong, Kenneth Chok, Albert Chan, Tan‐To Cheung, Jeff Wing‐Chiu Dai, Sui‐ling Sin, Ka‐Wing Ma, Kelvin Ng, Kevin Tak‐Pan Ng, Wai‐Kay Seto, Ching‐Lung Lai, Man‐Fung Yuen, Chung‐Mau Lo. Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 yearsHepatology 2017; 66(4): 1036 doi: 10.1002/hep.29191
5
Hussein A. AbdEl-maksoud, Mohamed G. Elharrif, Omnia Abd El-hamid, Saad M. Alsaab, Eman M. El-sorady. Monitoring of iron, lipid and liver profiles in Egyptian hepatitis C virus patients on sofosbuvir therapyJournal of Infection and Public Health 2022; 15(3): 277 doi: 10.1016/j.jiph.2022.01.008
6
James Fung, Tiffany Wong, Kenneth Chok, Albert Chan, Sui-ling Sin, Tan-to Cheung, Wing-Chiu Dai, Kelvin Ng, Kevin Ng, Kwan Man, Wai-kay Seto, Ching-Lung Lai, Man-Fung Yuen, Chung-Mau Lo. Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 MutationTransplantation 2017; 101(10): 2391 doi: 10.1097/TP.0000000000001883
7
Allison Mah, Alissa Wright. Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver TransplantationCurrent Infectious Disease Reports 2016; 18(2) doi: 10.1007/s11908-015-0514-5
8
Manuel Rodríguez, Juan Manuel Pascasio, Enrique Fraga, Javier Fuentes, Martín Prieto, Gloria Sánchez-Antolín, José Luis Calleja, Esther Molina, María Luisa García-Buey, María Ángeles Blanco, Javier Salmerón, María Lucía Bonet, José Antonio Pons, José Manuel González, Miguel Ángel Casado, Francisco Jorquera, the TENOSIMP-B Research Group. Tenofovir <i>vs</i> lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B studyWorld Journal of Gastroenterology 2017; 23(41): 7459-7469 doi: 10.3748/wjg.v23.i41.7459
9
James S. Park, Vijay Gayam, Calvin Q. Pan. Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti‐viralsAlimentary Pharmacology & Therapeutics 2020; 52(6): 944 doi: 10.1111/apt.15999
10
Nora V. Bergasa. Clinical Cases in Hepatology2022; : 203 doi: 10.1007/978-1-4471-4715-2_7
11
Daniel Hornuss, Anna Rudi, Lucas Koerner, Isabelle Mohr, Uta Merle, Cyrill Wehling, Christian Rupp, Michael T. Dill, Mohammad Golriz, Paul Schnitzler, Thorsten Brenner, Arianeb Mehrabi, Karl Heinz Weiss, Markus Mieth. HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective studyClinics and Research in Hepatology and Gastroenterology 2021; 45(2): 101496 doi: 10.1016/j.clinre.2020.07.003
12
L.‐Y. Mak, D. K.‐H. Wong, K.‐S. Cheung, W.‐K. Seto, C.‐L. Lai, M.‐F. Yuen. Review article: hepatitis B core‐related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infectionAlimentary Pharmacology & Therapeutics 2018; 47(1): 43 doi: 10.1111/apt.14376
13
Albert C.Y. Chan, James Y.Y. Fung, Chung Mau Lo. Liver transplantation and hepatitis B virus infectionCurrent Opinion in Organ Transplantation 2016; 21(2): 219 doi: 10.1097/MOT.0000000000000293
14
Experimental and Clinical Transplantation 2017; 15(2) doi: 10.6002/ect.2015.0277
15
Christophe Duvoux, Luca S. Belli, James Fung, Mario Angelico, Maria Buti, Audrey Coilly, Paolo Cortesi, François Durand, Cyrille Féray, Constantino Fondevila, Pascal Lebray, Silvia Martini, Frederik Nevens, Wojciech G. Polak, Mario Rizzetto, Riccardo Volpes, Fabien Zoulim, Didier Samuel, Marina Berenguer. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantationAlimentary Pharmacology & Therapeutics 2021; 54(5): 583 doi: 10.1111/apt.16374
16
Ming Shu Li, Zhou Hua Hou, Guo Zhu Yao, De Ming Tan. The strategy and efficacy of prophylaxis against hepatitis B virus recurrence after liver transplantation for HBV‐related diseases in the era of potent nucleos(t)ide analogues: A meta‐analysisJournal of Digestive Diseases 2021; 22(2): 91 doi: 10.1111/1751-2980.12959